PULM
Pulmatrix IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.35M
P/E Ratio
—
EPS
$-1.41
Beta
1.97
52W High
$9.37
52W Low
$1.18
50-Day MA
$2.29
200-Day MA
$4.12
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Pulmatrix Inc
Pulmatrix, Inc., a clinical-stage biopharmaceutical company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company is headquartered in Lexington, Massachusetts.
Fundamentals
| Revenue (TTM) | 3,000 |
| Gross Profit (TTM) | -38,000 |
| EBITDA | $-5.06M |
| Operating Margin | 0.00% |
| Return on Equity | -80.90% |
| Return on Assets | -45.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.04 |
| Price-to-Book | 1.26 |
| Price-to-Sales (TTM) | 2459.21 |
| EV/Revenue | 466.44 |
| EV/EBITDA | 1.57 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -99.90% |
| Shares Outstanding | $3.65M |
| Float | $3.63M |
| % Insiders | 0.74% |
| % Institutions | 9.77% |
Data last updated: 4/9/2026